CIK 0001739410 · <br>Emerging growth company
Rallybio Corp
Sign in to watch- Ticker
- RLYB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 851083789
- Phone
- 203- 859-3820
- Business address
- 234 CHURCH STREET, SUITE 1020, NEW HAVEN, CT, 06510
- Former names
- Rallybio Holdings, LLC
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SC 13D Stake Beneficial Ownership Report
- SC 13D Stake Beneficial Ownership Report
- SC 13D Stake Beneficial Ownership Report
- SC 13G Stake Amended Statement of Ownership
- 4 Open-market buy Director bought 615,384 shares at $13.00 ($7,999,992)
- 4 Open-market buy 10% owner bought 615,384 shares at $13.00 ($7,999,992)
- 3/A Insider 3/A
- 4 Open-market buy Director bought 576,923 shares at $13.00 ($7,499,999)
- 4 Open-market buy Director bought 307,692 shares at $13.00 ($3,999,996)
- 4 Open-market buy Director bought 76,923 shares at $13.00 ($999,999)
- SC 13G Stake Amended Statement of Ownership
- 4 Conversion See Remark 1 acquired 1,694,388 shares (conversion)
- 4 Open-market buy 10% owner bought 806,000 shares at $13.00 ($10,478,000)
- S-8 Other Securities Offered to Employees in Benefit Plans
- 8-K Event Material agreement · Shareholder rights changed · Bylaws or fiscal year change
- 424B4 Offering Prospectus
Page 14 of 16 · 312 filings